New and developing therapies for celiac disease.

about

Modeling of celiac disease immune response and the therapeutic effect of potential drugs Recent advances in the development of new treatments for celiac disease.Robust spectral analysis of videocapsule images acquired from celiac disease patients.The role of corticosteroids in celiac disease.

P2860

Q34798574-6593C669-8CA9-4D9D-B1D5-9208E4353DC5 Q38038684-797A4EB4-87F0-4B87-94F7-AA73F7C544A0 Q38849011-E33F550F-668A-4B71-B08F-C939FE0C2941 Q50489393-48FD9017-6427-4123-8228-5FC443A7B701

P2860

New and developing therapies for celiac disease.

Item

http://www.wikidata.org/entity/Q41173044

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

New and developing therapies for celiac disease.

@en

type

Item

label

New and developing therapies for celiac disease.

@en

prefLabel

New and developing therapies for celiac disease.

@en

P1476

New and developing therapies for celiac disease.

@en

P2093

Christina A Tennyson

http://www.w3.org/2001/XMLSchema#string

Peter H R Green

http://www.w3.org/2001/XMLSchema#string

Suzanne K Lewis

http://www.w3.org/2001/XMLSchema#string

P2860

Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal Digestion

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3

Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease

Structural basis for gluten intolerance in celiac sprue

A non-human primate model for gluten sensitivity.

Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue.

Need for follow up in coeliac disease.

Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.

P304

303-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1177/1756283X09342759

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21180558

http://www.w3.org/2001/XMLSchema#string

P932

3002532

http://www.w3.org/2001/XMLSchema#string

New and developing therapies for celiac disease.

about

P2860

P2860

New and developing therapies for celiac disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932